ArticleFrontiers in neurology2023

Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists - the RIC-ICH study.

Nils Kuklik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.